SageMedic Corporation Introduces Advisory Board to Enhance Cancer Diagnostics
SageMedic Corp, known as 'SAGE', based in Silicon Valley, is thrilled to announce the establishment of its Scientific and Medical Advisory Board (SAB). This board is made up of distinguished experts in cancer research and oncology, all committed to improving cancer diagnostics and helping oncologists customize treatments to better suit the individual needs of patients.
Notable Experts Joining the SAB
Leading this initiative is William Cance, MD, who has previously held the position of Chief Medical and Scientific Officer at the American Cancer Society. Dr. Cance highlights the significant challenges faced in cancer treatment, stating, "Cancer presents considerable obstacles, and many current advancements offer limited benefits. However, SAGE's innovative approach of testing therapies on live tumor tissue provides actionable results in just over a week, which could revolutionize precision medicine and significantly improve patient outcomes."
Other prominent members include:
Dr. Jorg Dietrich
Dr. Dietrich, MD, PhD, MBA, is the Director of the Cancer & Neurotoxicity Clinic and a leading expert in glioblastoma research at Massachusetts General Hospital and Harvard Medical School.
Dr. Amer Karam
A highly regarded gynecologic oncologist, Dr. Karam is the Director of Robotic Surgery in Gynecologic Oncology at Stanford University. He brings his expertise in chemosensitivity testing and minimally invasive techniques to the advisory board.
Dr. Scott Kopetz
As the Deputy Chair for Translational Research at MD Anderson Cancer Center, Dr. Kopetz focuses on gastrointestinal cancers and is well-known for his work with in-vitro organoid models.
Dr. Priya Kumthekar
Dr. Kumthekar, an Associate Professor of Neurology at the Northwestern University Feinberg School of Medicine, specializes in innovative treatment strategies for central nervous system tumors.
Dr. Konstantinos Votanopoulos
Dr. Votanopoulos, a prominent surgical professor at Atrium Health's Wake Forest Baptist Comprehensive Cancer Center, specializes in predicting responses to immunotherapy in collaboration with SAGE.
Dedication to Personalized Cancer Treatment
Chris Apfel, MD, MBA, Chair and CEO of SageMedic, expressed his enthusiasm about the formation of the SAB, stating, "It is a tremendous honor to have such a distinguished group of leaders on our advisory board. Their extensive expertise will broaden the horizons of precision medicine, allowing us to personalize cancer treatments like never before."
About SageMedic Corp
SageMedic is at the forefront of developing diagnostic solutions aimed at transforming oncology treatment outcomes. Their flagship product, the SAGE Oncotest™, utilizes AI-enhanced, in-vitro, live 3D microtumor technology, providing oncologists with vital insights to formulate personalized therapeutic strategies. This innovative approach ultimately strives to enhance the quality of life for cancer patients around the globe.
Contact Information
For further information about SageMedic Corp, please reach out to:
Mara Quigley, Co-President
(661) 255-8283
Frequently Asked Questions
What is the purpose of the Scientific and Medical Advisory Board at SageMedic?
The board's goal is to improve cancer diagnostics and assist oncologists in personalizing treatments for better patient outcomes.
Who leads the Scientific and Medical Advisory Board?
Dr. William Cance, a prominent figure in cancer research, is the leader of the advisory board.
What innovative technology does SageMedic use?
SageMedic employs the SAGE Oncotest™, which merges AI and in-vitro live 3D microtumor technologies to create personalized cancer treatment strategies.
How does the SAGE Oncotest™ benefit cancer patients?
This technology offers actionable insights that enable oncologists to tailor therapies specifically to the needs of individual patients, enhancing treatment effectiveness.
Where is SageMedic Corp based?
SageMedic Corp is headquartered in Silicon Valley, California, and focuses on developing advanced cancer diagnostic solutions.
